{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:09:26Z","timestamp":1778000966639,"version":"3.51.4"},"reference-count":64,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Pregnancy planning and genetic testing (PPGT) has emerged as a tool in reproductive healthcare, offering parents-to-be insight in their risks of having a child with a genetic disorder. This paper reviews the advantages, drawbacks and challenges associated with PPGT, providing some practical guidance for health care professionals. Advantages include identification of genetic risks, a possibility to informed reproductive decision-making, and the potential to reduce the parents-to-be risk for an affected child. Challenges and drawbacks include provision of service, ethical considerations, genetic counselling complexities, and the need to increase public and professional awareness by comprehensive education and accessibility. Practical guidance involves considerations for selecting appropriate candidates, counselling strategies, and how to integrate PPGT into existing healthcare frameworks. By addressing these factors, PPGT can offer an increased reproductive informed choice for the individual and the couple reducing the burden of disease in the family.<\/jats:p>","DOI":"10.3390\/genes15091205","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:39:16Z","timestamp":1726209556000},"page":"1205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pregnancy Planning and Genetic Testing: Exploring Advantages, and Challenges"],"prefix":"10.3390","volume":"15","author":[{"given":"Ulf","family":"Kristoffersson","sequence":"first","affiliation":[{"name":"Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, 22100 Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Johansson-Soller","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Karolinska University Hospital, 17176 Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Garcia-Herrero, S., Simon, B., and Garcia-Planells, J. (2020). The Reproductive Journey in the Genomic Era: From Preconception to Childhood. Genes, 11.","DOI":"10.3390\/genes11121521"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","article-title":"Responsible implementation of expanded carrier screening","volume":"24","author":"Henneman","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"hoaa063","DOI":"10.1093\/hropen\/hoaa063","article-title":"The ethics of preconception expanded carrier screening in patients seeking assisted reproduction","volume":"2021","author":"Goddijn","year":"2021","journal-title":"Hum. Reprod. Open"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","article-title":"Carrier screening for recessive disorders","volume":"20","author":"Antonarakis","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lazarin, G.A., Hawthorne, F., Collins, N.S., Platt, E.A., Evans, E.A., and Haque, I.S. (2014). Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114391"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"European Society of Human Genetics (2010). Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur. J. Hum. Genet., 18, 1271\u20131273.","DOI":"10.1038\/ejhg.2010.129"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009734.2016.1189470","article-title":"Ethical issues in preconception genetic carrier screening","volume":"121","author":"Kihlbom","year":"2016","journal-title":"Upsala J. Med. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Matar, A., H\u00f6glund, A.T., Segerdahl, P., and Kihlbom, U. (2020). Autonomous decisions by couples in reproductive care. BMC Med. Ethics, 21.","DOI":"10.1186\/s12910-020-00470-w"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jgc4.1676","article-title":"Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors","volume":"32","author":"Sagaser","year":"2023","journal-title":"J. Genet. Couns."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(23)02295-X","article-title":"Population screening requires robust evidence-genomics is no exception","volume":"403","author":"Turnbull","year":"2024","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/ejh.12076","article-title":"Thirty-year experience in preventing haemoglobinopathies in Greece: Achievements and potentials for optimisation","volume":"90","author":"Ladis","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/03630269.2014.938163","article-title":"Thalassemias and hemoglobinopathies in Turkey","volume":"38","author":"Canatan","year":"2014","journal-title":"Hemoglobin"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41525-024-00393-0","article-title":"Clinical application of next generation sequencing for Mendelian disease diagnosis in the Iranian population","volume":"9","author":"Abolhassani","year":"2024","journal-title":"NPJ Genom. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jmg-2022-108607","article-title":"Experience using singleton exome sequencing of probands as an approach to preconception carrier screening in consanguineous couples","volume":"60","author":"Valenzuela","year":"2023","journal-title":"J. Med. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bruins, D., Onstwedder, S.M., Cornel, M.C., Ausems, M.G.E.M., van Mil, M.H.W., and Rigter, T. (2024). Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers\u2019 Websites. Genes, 15.","DOI":"10.3390\/genes15040517"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.c.30202","article-title":"Moving up the slippery slope: Mandated genetic screening on Cyprus","volume":"151C","author":"Cowan","year":"2009","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/pd.5611","article-title":"International perspectives on the implementation of reproductive carrier screening","volume":"40","author":"Delatycki","year":"2020","journal-title":"Prenat. Diagn."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AOG.0000000000002139","article-title":"Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel","volume":"130","author":"Stevens","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.gim.2022.01.003","article-title":"Correspondence on \u201cScreening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)\u201d by Gregg et al.","volume":"24","author":"Schmidtke","year":"2022","journal-title":"Genet. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12687-022-00593-0","article-title":"Carrier detection probabilities for autosomal recessive variants in unrelated and consanguineous couples\u2014An evaluation of the 86 genes of the ACMG \u2018Tier 3\u2019 panel","volume":"13","author":"Schmidtke","year":"2022","journal-title":"J. Community Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database","volume":"28","author":"Lambert","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41525-022-00316-x","article-title":"Assessing clinical utility of preconception expanded carrier screening regarding residual risk for neurodevelopmental disorders","volume":"7","author":"Boonsawat","year":"2022","journal-title":"NPJ Genom. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ajhg.2022.10.012","article-title":"Addressing the challenges of polygenic scores in human genetic research","volume":"109","author":"Novembre","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12687-023-00645-z","article-title":"Clinical utility of polygenic risk scores: A critical 2023 appraisal","volume":"14","author":"Koch","year":"2023","journal-title":"J. Community Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41431-019-0516-0","article-title":"GP-provided couple-based expanded preconception carrier screening in the Dutch general population: Who accepts the test-offer and why?","volume":"28","author":"Schuurmans","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/humupd\/dmaa001","article-title":"Interest in expanded carrier screening among individuals and couples in the general population: Systematic review of the literature","volume":"26","author":"Chokoshvili","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2018.12.004","article-title":"Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism","volume":"126","author":"Nijmeijer","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrg3424","article-title":"A genomic view of mosaicism and human disease","volume":"14","author":"Biesecker","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02598968","article-title":"Patients\u2019 interpretations of probability terms","volume":"6","author":"Mazur","year":"1991","journal-title":"J. Gen. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1539-6924.2008.01137.x","article-title":"Probability information in risk communication: A review of the research literature","volume":"29","author":"Visschers","year":"2009","journal-title":"Risk Anal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/135910539700200104","article-title":"Understanding Life\u2019s Lottery: An Evaluation of Studies of Genetic Risk Awareness","volume":"2","author":"Hallowell","year":"1997","journal-title":"J. Health Psychol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12687-016-0268-2","article-title":"Swedish healthcare providers\u2019 perceptions of preconception expanded carrier screening (ECS)\u2014A qualitative study","volume":"7","author":"Matar","year":"2016","journal-title":"J. Community Genet."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Archibald, A.D., McClaren, B.J., Caruana, J., Tutty, E., King, E.A., Halliday, J.L., Best, S., Kanga-Parabia, A., Bennetts, B.H., and Cliffe, C.C. (2022). The Australian Reproductive Genetic Carrier Screening Project (Mackenzie\u2019s Mission): Design and Implementation. J. Pers. Med., 12.","DOI":"10.3390\/jpm12111781"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5694\/mja2.52261","article-title":"Medicare-funded reproductive genetic carrier screening in Australia has arrived: Are we ready?","volume":"220","author":"Rogers","year":"2024","journal-title":"Med. J. Aust."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bioe.12555","article-title":"The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood","volume":"33","author":"Dondorp","year":"2019","journal-title":"Bioethics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12687-011-0074-9","article-title":"Preconception care and genetic risk: Ethical issues","volume":"3","author":"Dondorp","year":"2012","journal-title":"J. Community Genet."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"J\u00e4mterud, S.M., and Snoek, A. (2023). Preconception Expanded Carrier Screening: A Discourse Analysis of Dutch Webpages. Healthcare, 11.","DOI":"10.3390\/healthcare11101511"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2010.tb03836.x","article-title":"Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening","volume":"193","author":"Modra","year":"2010","journal-title":"Med. J. Aust."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/GIM.0b013e318188d04c","article-title":"Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands","volume":"10","author":"Lakeman","year":"2008","journal-title":"Genet. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/pd.6033","article-title":"Counseling for personal health implications identified during reproductive genetic carrier screening","volume":"41","author":"Gbur","year":"2021","journal-title":"Prenat. Diagn."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e31815f524f","article-title":"A systematic review of perceived risks, psychological and behavioral impacts of genetic testing","volume":"10","author":"Heshka","year":"2008","journal-title":"Genet. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/jcm3031033","article-title":"Carrier Screening: Past, Present, and Future","volume":"3","author":"Bajaj","year":"2014","journal-title":"J. Clin. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/ajo.13206","article-title":"Socioeconomic status and uptake of reproductive carrier screening in Australia","volume":"60","author":"Robson","year":"2020","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jgc4.1457","article-title":"Interest in and uptake of genetic counseling for preconception carrier screening when offered to predominantly white reproductive-age persons seeking gynecologic care at a single U.S. academic medical center","volume":"31","author":"Nesbit","year":"2022","journal-title":"J. Genet. Couns."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1467-8519.00135","article-title":"Medicalization as a moral problem for preventative medicine","volume":"13","author":"Verweij","year":"1999","journal-title":"Bioethics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41431-022-01178-8","article-title":"Societal implications of expanded universal carrier screening: A scoping review","volume":"31","author":"Janssens","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Edwards, S., and Laing, N. (2022). Genetic Counselling Needs for Reproductive Genetic Carrier Screening: A Scoping Review. J. Pers. Med., 12.","DOI":"10.3390\/jpm12101699"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12687-017-0309-5","article-title":"With expanded carrier screening, founder populations run the risk of being overlooked","volume":"8","author":"Mathijssen","year":"2017","journal-title":"J. Community Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jmedgenet-2018-105362","article-title":"Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening","volume":"55","author":"Ong","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/03009734.2016.1218575","article-title":"Swedish parents\u2019 interest in preconception genetic carrier screening","volume":"121","author":"Ekstrand","year":"2016","journal-title":"Upsala J. Med. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"W\u00f6hlke, S., Schaper, M., and Schicktanz, S. (2019). How Uncertainty Influences Lay People\u2019s Attitudes and Risk Perceptions Concerning Predictive Genetic Testing and Risk Communication. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00380"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jgc4.1207","article-title":"An ethical framework for genetic counseling in the genomic era","volume":"29","author":"Jamal","year":"2020","journal-title":"J. Genet. Couns."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ajmg.a.38583","article-title":"Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results","volume":"176","author":"Kraft","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10897-015-9851-7","article-title":"\u201cIs It Worth Knowing?\u201d Focus Group Participants\u2019 Perceived Utility of Genomic Preconception Carrier Screening","volume":"25","author":"Schneider","year":"2016","journal-title":"J. Genet. Couns."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pd.5109","article-title":"Expanded carrier screening for monogenic disorders: Where are we now?","volume":"38","author":"Chokoshvili","year":"2018","journal-title":"Prenat. Diagn."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.fertnstert.2017.11.030","article-title":"Expanded carrier screening: What the reproductive endocrinologist needs to know","volume":"109","author":"Dungan","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Klein, D., van Dijke, I., van Langen, I.M., Dondorp, W., Lakeman, P., Henneman, L., and Cornel, M.C. (2024). Perceptions of reproductive healthcare providers regarding their involvement in offering expanded carrier screening in fertility clinics: A qualitative study. Reprod. Biomed. Online, 49.","DOI":"10.1016\/j.rbmo.2024.103857"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/pd.6003","article-title":"Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study","volume":"41","author":"Weijerman","year":"2021","journal-title":"Prenat. Diagn."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.gim.2022.08.029","article-title":"Estimation of the number of people with Down syndrome in Australia and New Zealand","volume":"24","author":"Skladzien","year":"2022","journal-title":"Genet. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41436-019-0455-8","article-title":"Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen","volume":"21","author":"Beauchamp","year":"2019","journal-title":"Genet. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12687-018-0371-7","article-title":"Ethics in genetic counselling","volume":"10","author":"Clarke","year":"2019","journal-title":"J. Community Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PPO.0000000000000391","article-title":"Adverse Events in Genetic Testing: The Fourth Case Series","volume":"25","author":"Farmer","year":"2019","journal-title":"Cancer J."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/9\/1205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:55:34Z","timestamp":1760111734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/9\/1205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["genes15091205"],"URL":"https:\/\/doi.org\/10.3390\/genes15091205","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}